|
B3GNT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.362400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.089800E-01 |
| Normal-vs-Stage2 |
9.245900E-02 |
| Normal-vs-Stage3 |
2.161000E-01 |
| Normal-vs-Stage4 |
1.938330E-02 |
| Stage1-vs-Stage2 |
9.661500E-02 |
| Stage1-vs-Stage3 |
2.671400E-01 |
| Stage1-vs-Stage4 |
1.014140E-02 |
| Stage2-vs-Stage3 |
4.292400E-01 |
| Stage2-vs-Stage4 |
4.976000E-01 |
| Stage3-vs-Stage4 |
1.085590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.141000E-01 |
| Normal-vs-AfricanAmerican |
8.593200E-01 |
| Normal-vs-Asian |
7.336800E-01 |
| Caucasian-vs-AfricanAmerican |
6.039000E-01 |
| Caucasian-vs-Asian |
6.352600E-01 |
| AfricanAmerican-vs-Asian |
9.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.874000E-02 |
| Normal-vs-Female |
4.158400E-01 |
| Male-vs-Female |
6.700300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.264800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.781800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.460500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.415800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.722900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.680010E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.804800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.987800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.808400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.295600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.600000E-01 |
| Classical-VS-Follicular |
7.958500E-04 |
| Classical-VS-Other |
4.973400E-01 |
| Classical-VS-Normal |
7.305400E-01 |
| Tall-VS-Follicular |
1.578610E-01 |
| Tall-VS-Other |
7.227400E-01 |
| Tall-VS-Normal |
3.737400E-01 |
| Follicular-VS-Other |
6.552000E-01 |
| Follicular-VS-Normal |
8.601500E-03 |
| Other-VS-Normal |
4.378400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.335500E-02 |
| Normal-vs-N1 |
3.958800E-01 |
| N0-vs-N1 |
6.313200E-01 |
|
|
